Latest Peptide Research
Stay informed about the latest research and developments
Filter Articles
Recent research on Sermorelin: Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
Recent research on Melanotan II: 5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.
Recent research on Melanotan II: Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner.
Receptor pharmacology study characterizing melanotan II binding to melanocortin receptors (MC1R, MC3R, MC4R). Analyzes receptor selectivity, signal transduction pathways, and downstream effects in transfected cell expression systems.
Recent research on DSIP: Electronic Prediction of Chemical Contaminants in Aroma of Brewed Roasted Coffee and Quantification of Acrylamide Levels.
Recent research on GH-FRAG 176-191: Chitosan/Hyaluronan and Alginate-Nanohydroxyapatite Biphasic Scaffold as a Promising Matrix for Osteoarthritis Disorders.
Recent research on TB-500: Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro.
Recent research on ARA-290: Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke.
Recent research on GLOW Blend: Computational, optical and feasibility studies of organic luminescence TMB-PPT blend for photovoltaic application.
Cellular biology investigation of epithalon's effects on telomerase activation and potential anti-senescence mechanisms. Examines telomere length maintenance, cell cycle regulation, and longevity-related pathways in cultured cell models.
Recent research on FOXO4-DRI: Cellular Senescence Contributes to the Progression of Hyperoxic Bronchopulmonary Dysplasia.
Recent research on Lys-Glu (Vilon): Graphene oxide nanosheets conjugated PEG-Glu-Lys-Glu copolymer drug delivery system improves drug-loading rates and enables reduction-sensitive drug release and drug tracking.